- Home
- DXR vs NYC Comparison
DXR vs NYC Comparison
Compare DXR & NYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXR
- NYC
- Stock Information
- Founded
- DXR 1970
- NYC 2013
- Country
- DXR United States
- NYC United States
- Employees
- DXR N/A
- NYC N/A
- Industry
- DXR Medical/Dental Instruments
- NYC Real Estate
- Sector
- DXR Health Care
- NYC Finance
- Exchange
- DXR Nasdaq
- NYC Nasdaq
- Market Cap
- DXR 46.1M
- NYC 40.9M
- IPO Year
- DXR N/A
- NYC N/A
- Fundamental
- Price
- DXR $10.14
- NYC $13.55
- Analyst Decision
- DXR Strong Buy
- NYC
- Analyst Count
- DXR 1
- NYC 0
- Target Price
- DXR $25.00
- NYC N/A
- AVG Volume (30 Days)
- DXR 3.2K
- NYC 4.2K
- Earning Date
- DXR 01-01-0001
- NYC 08-08-2025
- Dividend Yield
- DXR N/A
- NYC N/A
- EPS Growth
- DXR 86.16
- NYC N/A
- EPS
- DXR 0.11
- NYC N/A
- Revenue
- DXR $119,714.00
- NYC $58,397,000.00
- Revenue This Year
- DXR N/A
- NYC $8.40
- Revenue Next Year
- DXR N/A
- NYC $1.62
- P/E Ratio
- DXR $92.00
- NYC N/A
- Revenue Growth
- DXR N/A
- NYC N/A
- 52 Week Low
- DXR $6.55
- NYC $7.89
- 52 Week High
- DXR $10.23
- NYC $16.30
- Technical
- Relative Strength Index (RSI)
- DXR 65.31
- NYC 51.18
- Support Level
- DXR $9.05
- NYC $13.63
- Resistance Level
- DXR $9.90
- NYC $14.73
- Average True Range (ATR)
- DXR 0.29
- NYC 0.78
- MACD
- DXR 0.02
- NYC -0.27
- Stochastic Oscillator
- DXR 100.00
- NYC 22.08
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
About NYC American Strategic Investment Co.
American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.